Popular Posts

Tuesday, 18 September 2018

Shell targets lower methane emissions for oil and gas assets

Royal Dutch Shell plc (Shell) announced a target to maintain methane emissions intensity below 0.2 percent by 2025. This target covers all oil and gas assets for which Shell is the operator.
“This methane target complements Shell’s ambition to cut the Net Carbon Footprint of our energy products by around half by 2050, which we announced in November 2017. It is a further demonstration of our continued focus on tackling greenhouse gas emissions. Such efforts are a critical part of Shell’s strategy to thrive during the global energy transition by providing more and cleaner energy,” said Maarten Wetselaar, Shell’s integrated gas & new energies director.
To maintain this methane target, Shell is implementing programmes, including using infrared cameras to scan for methane emissions, deploying advanced technology to repair leaks, and replacing high-bleed pneumatically-operated controllers with low emission alternatives.
Shell recognises that there remains uncertainty with measuring methane emissions. “This is an industry-wide issue and we need to fix this fast,” said Wetselaar. “We must get a much more accurate understanding of how much we are emitting.”
The target for methane – which has a higher impact on global warming than carbon dioxide when released into the atmosphere – will be measured against a baseline Shell leak rate, which is currently estimated to range from 0.01 percent to 0.8 percent across the company’s oil and gas assets.

Indian govt bans Saridon, 327 other combination drugs

The health ministry of India has, with immediate effect, put a ban on manufacture, sale, and distribution of 328 fixed-dose combinations (FDCs) of drugs and restricted another six. This marks an end of the legal battle between the ministry and the manufacturers of these drugs. The ministry has been working since 2016 to ban these “irrational” and “unsafe” drugs.
Among the roughly 6,000 brands estimated to be affected by the ban are popular drugs like the painkiller Saridon, the skin cream Panderm, combination diabetes drug Gluconorm, antibiotic Lupidicl, x and antibacterial Taxim AZ.
The government had banned 344 FDCs on March 10, 2016, and later added five more to this list. However, manufacturers of these drugs contested the ban in various high courts and the Supreme Court. The SC on December 15, 2017, asked for the matter to be examined by the Drugs Technical Advisory Board. DTAB concluded in its report that there was no therapeutic justification for the ingredients in 328 FDCs and that these could be a risk to people. The board recommended banning them.
In the case of six other FDCs, the board recommended restricted manufacture and sale subject to certain conditions based on their therapeutic justification. The SC ruled that the government could not use the DTAB report to prohibit 15 of the 344 drugs in the original list as these have been manufactured in India since before 1988. This exception covered several popular cough syrups, painkillers and cold medication with sales amounting to over Rs 740 crore annually. However, the court told the ministry that it could still look into the safety of these 15 drugs by initiating a fresh investigation if it wanted to ban them.

Sunday, 16 September 2018

Lanxess commissions new production line for additives

Lanxess has commissioned a new production line at its Mannheim site for the synthesis of dimercaptothiadiazole (DMTD) derivatives. These chemicals are added to lubricants as multifunctional additives. The production line, which started in May 2018, doubles the annual production capacity of these speciality additives. The investment volume is in the single-digit-million-euro range.
“With this investment, we have responded to the increased customer demand for these specialities. The new plant will enable us to meet their requirements for high-quality lubricant additives, but also helps us acquire new customers, and further develop our own package solutions for a rapidly growing market,” said Dr Martin Sawe, head of the lubricant additives business line in Lanxess’s additives (ADD) business unit.
Speciality products for the lubricant industry
DMTD derivatives are multifunctional additives and are initially used as corrosion protection for lubricants in contact with steel alloys containing so-called nonferrous metals such as copper, nickel or cobalt. They prevent the leaching of nonferrous metal ions from the alloy, protect the metal surface from aggressive chemicals, and thus guarantee the integrity and longevity of steel alloys. With to their metal-surface bond, they also act as lubricants, even when under extreme conditions and high pressures metal surfaces start contacting each other.

IFF gets final antitrust clearance for acquisition of Frutarom

International Flavors & Fragrances Inc (IFF) said that it has received antitrust clearance from all relevant antitrust authorities around the world to acquire Frutarom. All applicable antitrust and competition laws have been satisfied.
“We are pleased that we’ve received our final antitrust clearance from Russia to proceed with our combination with Frutarom. 

FormFutura to distribute DSM’s filaments

Royal DSM said that FormFutura will distribute its high-performance additive manufacturing filaments to customers in the fast-growing additive manufacturing/3D printing industry.
The collaboration gives manufacturers, OEMs, designers and 3D printing service bureaus access to DSM additive manufacturing filaments for prototyping and industrial parts production.
A 25-year pioneer in stereolithography, DSM started developing high-performance filaments based on its engineering plastics portfolio. Building on the company’s deep market-specific application understanding and expertise, DSM is further expanding its additive manufacturing activities into all polymer processing technology platforms - including experience from years of research in Selective Laser Sintering (SLS), Multi Jet Fusion, Ink Jet and Binder Jet processes.
FormFutura is a global supplier of filaments to the additive manufacturing industry, delivering excellent customer service, quality and service throughout the entire supply chain. Due to their operational effectiveness and customer focus, they can unburden customers and add value to their supply chain by offering favourable purchase conditions and an extremely fast supply and (re)stocking of DSM products.
“At DSM, we believe that partnerships across the additive manufacturing ecosystem are critical to unlocking the full potential of this new technology. Our collaboration with FormFutura allows us to extend our global reach, providing customers with easy ordering and support for our high-performance filaments across all regions and markets,” said Jill Cohen, global director marketing & sales for DSM Additive Manufacturing. 

Thursday, 13 September 2018

RPM acquires leading provider of insulated concrete products

RPM International Inc (RPM) said that it has acquired Nudura Corporation, the leading manufacturer and distributor of insulated concrete forms (ICF) in North America. Based in Ontario, Canada, Nudura has annual net sales in excess of $40 million.
Nudura provides four series of ICF wall systems, consisting of foam boards made from expanded polystyrene (EPS) and integral hinged plastic webs that hold both sides of the boards together. Concrete is then poured into the form to make an insulated concrete wall system. Nudura also offers a range of complementary building envelope products. A niche and emerging product in the building materials industry, ICFs provide enhanced energy efficiency and superior insulation, as well as greater resistance to fire, hurricanes, earthquakes and flooding, compared to traditional construction methods.
The company has three strategically located manufacturing plants and an extensive network of 260 locally based professional distributors in key North American markets. Its patented products are sold to design professionals, architects and contractors for residential and commercial applications. They are used to construct homes, schools, medical and commercial facilities, and other buildings that can benefit from the insulative and structural properties of ICF construction.

KBR nitric acid technology selected for Kemerovo Azot plant

KBR Inc (KBR) has been awarded a license, engineering and proprietary equipment contract for KBR Weatherly's Nitric Acid technology by Kemerovo Azot JSC.
Weatherly Inc is a wholly owned subsidiary of KBR.
Under the terms of the contract, KBR will provide technology licensing and basic engineering design (LBED) as well as proprietary equipment for Kemerovo Azot's plant in Kemerovo, Russia. This is a 500 tons per day nitric acid plant and is targeted to be in operation by 2021. Nitric acid will be used for the production of ammonium nitrate, one of the major nitrogen fertilizers.

Follow by Email